OFIX - OFIX SHAREHOLDER ALERT: Hagens Berman National Trial Attorneys Encourages Orthofix Medical (OFIX) Investors with Substantial Losses to Contact Firm's Attorneys Firm Investigating Events Leading to Termination of Senior Management | Benzinga

SAN FRANCISCO, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Orthofix Medical Inc. (NASDAQ:OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys.

Visit: www.hbsslaw.com/investor-fraud/ofix
Contact An Attorney Now: OFIX@hbsslaw.com
         844-916-0895

Orthofix Medical Inc. (OFIX) Investigation:

The investigation focuses on Orthofix's recent assurances that "[i]t is our fundamental policy to conduct business in accordance with the highest ethical and legal standards."

On Sept. 12, 2023, Orthofix abruptly terminated CEO Keith Valentine, CFO John Bostjancic, and Chief Legal Officer Patrick Keran "for cause." The company explained that "the Board ...

OFIX) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Events Leading to Termination of Senior Management>Full story available on Benzinga.com